The global Hypoplastic Left Heart Syndrome market is growing due to advancements in minimally invasive procedures, stem cell therapies, and AI-driven diagnostics. Increased research funding and regulatory support are enhancing treatment access, particularly in North America and Europe.
Hypoplastic Left Heart Syndrome (HLHS) Market Size - 2035
According to the IMARC Group, The hypoplastic left heart syndrome (HLHS) market growth at a CAGR of 8.15% by 2025-2035.
https://www.imarcgroup.com/hypoplastic-left-heart-syndrome-market
12:16 PM - Jul 18, 2025 (UTC)
